Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "multiple pro-inflammatory and oxidative stress pathways" collectively refers to a set of interconnected molecular signaling routes involved in mediating inflammation and the production of reactive oxygen species (ROS). Key pathways include the NF-κB and MAPK cascades, as well as signaling driven by cytokines, chemokines, and receptors such as IL-1β, TNF-α, and toll-like receptors. Oxidative stress pathways involve enzymes like NADPH oxidases, mitochondrial ROS generation, and antioxidant defense systems (e.g., Nrf2 pathway). These pathways regulate numerous physiological and pathological processes—such as immune cell activation, cytokine production, cell proliferation, apoptosis, and tissue damage in disease contexts (e.g., cardiovascular disease, neurodegeneration, cancer, and infection)[1][2][3][4][5][6]. Because the phrase does not specify a single molecular entity, it is not a canonical drug target, but rather a functional concept encompassing multiple molecular participants and regulatory networks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple pro-inflammatory and oxidative stress pathways.